Changyi Lin

发表

Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.

S. Yeh, Chawnshang Chang, Gonghui Li, 2016, Cancer letters.

Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals

S. Yeh, Chawnshang Chang, Lei Li, 2015, Oncotarget.

Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression.

S. Yeh, Chawnshang Chang, Y. Niu, 2019, Cancer letters.

Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer

S. Yeh, Chawnshang Chang, Y. Niu, 2020, Cell Death & Disease.

Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression.

Jun Luo, E. Antonarakis, S. Yeh, 2017, European urology.

The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status12

Hong-Chiang Chang, Chawnshang Chang, H. Miyamoto, 2015, Neoplasia.

Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7).

S. Yeh, Chawnshang Chang, Lei Li, 2017, Cancer letters.

ASC-J9(®) suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L.

Chawnshang Chang, Lei Li, Rong-hao Wang, 2016, Cancer letters.

New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals

Hong-Chiang Chang, S. Yeh, Chawnshang Chang, 2016, Oncotarget.

Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network

S. Yeh, Chawnshang Chang, Chiuan-Ren Yeh, 2018, Oncogene.

ASC-J9® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3.

Chawnshang Chang, Y. Niu, Gonghui Li, 2018, Cancer letters.

TR2 and TR4 Orphan Nuclear Receptors: An Overview.

Hong-Chiang Chang, Chawnshang Chang, Dong-Rong Yang, 2017, Current topics in developmental biology.